公司资料
Zimmer Biomet 股价、新闻与催化剂
- 股票代码:
- ZBH
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股票表现
98.20 USD (-2.43%)
收盘价
最后更新: 2026年8月17日
16.2B USD
市值
股价为何变动
As of Aug 17, 2026, ZBH closed down 2.43% at $98.20. No new same-company headline was identified in the current news window.
公司概览
业务概览
Zimmer Biomet is a medical technology company focused on orthopedics, joint replacement, and musculoskeletal solutions. Its business is tied to procedure volumes and the adoption of implant and surgical systems.
所在地与行业分类
Headquartered in the United States and listed on NYSE, Zimmer Biomet has a global orthopedic footprint. It is a medtech company rather than a biotech name.
商业模式特征
The business generates revenue through implants, surgical systems, and procedure-linked products. Investors watch joint-replacement demand, surgical volumes, product launches, and margin recovery.
生物医药行业定位
Zimmer Biomet sits outside biotech but inside the broader healthcare technology stack. It is influenced by procedure trends and device adoption, not by drug approvals or clinical readouts.
未来催化剂
- Zimmer Biomet should be watched for ROSA robotics adoption, hip and knee procedure growth, and continued product-cycle execution. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。